Childhood Astrocytoma — Trials

Childhood Astrocytoma — Trials · CancerIndex

Clinical trials

Registered studies

33 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01553149	Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma	completed	Phase 2	75	National Cancer Institute (NCI)NIH	4	Jan 7, 2025	clinicaltrials
NCT01236560	Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma	completed	Phase 2 / Phase 3	101	National Cancer Institute (NCI)NIH	2	Feb 20, 2024	clinicaltrials
NCT01514201	Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas	completed	Phase 1 / Phase 2	66	National Cancer Institute (NCI)NIH	1	Aug 13, 2019	clinicaltrials

Data updated 23 days agoSource updated Jan 7, 2025source: clinicaltrials